Atossa Therapeutics, Inc. (ATOS)

NASDAQ: ATOS · IEX Real-Time Price · USD

1.530

+0.020 (1.32%)

At close: May 1, 2024, 4:00 PM

1.510

-0.020 (-1.31%)

After-hours: May 1, 2024, 5:32 PM EDT

Atossa Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2010
Net Income	-30.09	-26.96	-20.61	-22.33	-17.24	-22.88	-10.69	-6.37	-15.76	-14.66	Upgrade
Depreciation & Amortization	0.02	0.01	0.02	0.05	0.05	0.04	0.13	0.3	0.27	0.48	Upgrade
Share-Based Compensation	4.62	6.79	5.27	3.02	8.84	2.46	0.79	0.88	0.84	0.56	Upgrade
Other Operating Activities	4.51	-0.6	-1.16	3.19	-0.79	-0.06	0.61	-0.19	0.69	3.07	Upgrade
Operating Cash Flow	-20.94	-20.76	-16.47	-11.57	-9.13	-8.96	-6.59	-5.37	-13.95	-10.56	Upgrade
Capital Expenditures	-0.01	-0.03	-0.01	-0.01	-0.01	-0.11	0	-0.01	-0.13	0.16	Upgrade
Change in Investments	0	-4.7	0	0	0	0	0	0	0	0	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-	-0.16	-0.5	Upgrade
Investing Cash Flow	-0.01	-4.73	-0.01	-0.01	-0.01	-0.11	0	-0.01	-0.29	-0.34	Upgrade
Share Issuance / Repurchase	-1.48	0	113.88	33.62	11.34	0	10.78	4.7	9.46	13.16	Upgrade
Debt Issued / Paid	0	0	0	0	0	0	0	0	0	-0.1	Upgrade
Other Financing Activities	-	-	-0.57	4.93	-	12.29	-	-	-	-	Upgrade
Financing Cash Flow	-1.48	0	113.3	38.55	11.34	12.29	10.78	4.7	9.46	13.06	Upgrade
Net Cash Flow	-22.43	-25.49	96.82	26.97	2.2	3.22	4.19	-0.69	-4.78	2.16	Upgrade
Free Cash Flow	-20.96	-20.79	-16.48	-11.58	-9.14	-9.07	-6.59	-5.38	-14.08	-10.4	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-	-	-	-801139.42%	-25901.96%	Upgrade
Free Cash Flow Per Share	-0.17	-0.16	-0.14	-1.02	-1.07	-2.18	-6.76	-21.92	-89.18	-77.85	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).